Abstract
Introduction
The Merendino (MER) procedure has been evaluated as an alternative to transthoracic esophageal resection (TER) for early stage Barrett’s carcinoma. Apart from reducing morbidity and mortality, improvements concerning postoperative health-related quality of life (HRQL) have been postulated. The aim of our study was to compare HRQL between these procedures.
Materials and methods
Between July 2000 and July 2007, 117 patients with early Barrett’s carcinoma underwent surgery. Patients with tumor recurrence were excluded from the study. HRQL was assessed 1 and 2 years after surgery using the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire (EORTC-QLQ-C30) and the QLQ-OES18 module. Patients recently diagnosed with early Barrett’s carcinoma served as controls. Symptoms that showed a difference of more than ten between the control and the study groups were considered clinically relevant and were tested for significant differences between the study groups using the Mann–Whitney U test (p < 0.05).
Results
The response rates for the questionnaires ranged between 70 and 93 %. In the MER group, more items reflected a clinical relevant impairment of HRQL than in the TER group. Significant complaints in the MER group included nausea/vomiting, appetite loss, local pain, difficulties with social eating, and choking. Moreover, we found a significant restriction concerning global health and emotional and social functioning in this group 1 year after surgery. 2 years postoperatively, hardly any differences between the operative techniques could be detected. The only symptom in favor of the MER procedure was a better dysphagia score postoperatively.
Conclusion
Our study suggests that MER procedure is not superior to subtotal esophagectomy with regard to HRQL.
Similar content being viewed by others
References
Jemal A, Murray T, Ward E et al (2005) Cancer statistics. CA Cancer J Clin 1:10–30
Buttar NS, Wang KK, Sebo TJ et al (2001) Extent of high-grade dysplasia in Barrett’s esophagus correlates with risk of adenocarcinoma. Gastroenterology 7:1630–1639
Aldulaimi DM, Cox M, Nwokolo CU et al (2005) Barrett’s surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival. Eur J Gastroenterol Hepatol 9:943–950
Fountoulakis A, Zafirellis KD, Dolan K et al (2004) Effect of surveillance of Barrett’s oesophagus on the clinical outcome of oesophageal cancer. Br J Surg 8:997–1003
Jamieson GG, Mathew G, Ludemann R et al (2004) Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 8:943–947
Viklund P, Lindblad M, Lu M et al (2006) Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg 2:204–211
Scarpa M, Valente S, Alfieri R et al (2011) Systematic review of health-related quality of life after esophagectomy for esophageal cancer. World J Gastroenterol 42:4660–4674
Scarpa M, Saadeh LM, Fasolo A et al (2013) Health-related quality of life in patients with oesophageal cancer: analysis at different steps of the treatment pathway. J Gastrointest Surg 3:421–433
Tatematsu N, Hasegawa S, Tanaka E et al (2013) Impact of oesophagectomy on physical fitness and health-related quality of life in patients with oesophageal cancer. Eur J Cancer Care (Engl) 22(3):308–313
Chennat J, Konda VJA, Ross AS et al (2009) Complete Barrett’s eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma: an American single-center experience. Am J Gastroenterol 11:2684–2692
Dunbar KB, Spechler SJ (2012) The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol 6:850–862 quiz 863
Pech O, Behrens A, May A et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 9:1200–1206
Pech O, Bollschweiler E, Manner H et al (2011) Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 1:67–72
Omloo JMT, Lagarde SM, Hulscher JBF et al (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 6:992–1000 discussion 1000–1001
Stein HJ, Feith M, Mueller J et al (2000) Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg 6:733–742
Merendino KA, Dillard DH (1955) The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiologic abnormalities at the esophagogastric junction; with special reference to reflux esophagitis, cardiospasm and esophageal varices. Ann Surg 3:486–506
Gerzic ZB (1997) Modification of the Merendino procedure. Dis Esophagus 4:270–275
Gaissert HA, Mathisen DJ, Grillo HC et al (1993) Short-segment intestinal interposition of the distal esophagus. J Thorac Cardiovasc Surg 5:860–866 discussion 866–867
Picchio M, Lombardi A, Zolovkins A et al (1997) Jejunal interposition for peptic stenosis of the esophagus following esophagomyotomy for achalasia. Int Surg 2:198–200
Parameswaran R, McNair A, Avery KNL et al (2008) The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review. Ann Surg Oncol 9:2372–2379
Bennett C, Vakil N, Bergman J et al (2012) Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2:336–346
Pech O, May A, Rabenstein T et al (2007) Endoscopic resection of early oesophageal cancer. Gut 11:1625–1634
Ando S, Tsuji H (2008) Surgical technique of vagus nerve-preserving gastrectomy with D2 lymphadenectomy for gastric cancer. ANZ J Surg 3:172–176
Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 5:365–376
Blazeby JM, Conroy T, Hammerlid E et al (2003) Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 10:1384–1394
Fayers PM (2008) Evaluating the effectiveness of using PROs in clinical practice: a role for cluster-randomised trials. Qual Life Res 10:1315–1321
Viklund P, Wengström Y, Rouvelas I et al (2006) Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 10:1407–1414
Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1:139–144
King MT (1996) The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 6:555–567
de Boer AGEM, van Lanschot JJB, van Sandick JW et al (2004) Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 20:4202–4208
Blazeby JM, Farndon JR, Donovan J et al (2000) A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 8:1781–1787
Moraca RJ, Low DE (2006) Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg 6:545–549 discussion 549–551
Parameswaran R, Blazeby JM, Hughes R et al (2010) Health-related quality of life after minimally invasive oesophagectomy. Br J Surg 4:525–531
Rutegård M, Lagergren J, Rouvelas I et al (2008) Population-based study of surgical factors in relation to health-related quality of life after oesophageal cancer resection. Br J Surg 5:592–601
Barbour AP, Lagergren P, Hughes R et al (2008) Health-related quality of life among patients with adenocarcinoma of the gastro-oesophageal junction treated by gastrectomy or oesophagectomy. Br J Surg 1:80–84
Djärv T, Lagergren J, Blazeby JM et al (2008) Long-term health-related quality of life following surgery for oesophageal cancer. Br J Surg 9:1121–1126
Lagergren P, Avery KNL, Hughes R et al (2007) Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer 3:686–693
Lee SS, Ryu SW, Kim IH et al (2012) Quality of life beyond the early postoperative period after laparoscopy-assisted distal gastrectomy: the level of patient expectation as the essence of quality of life. Gastric Cancer 3:299–304
Sullivan M, Tanzer M, Reardon G et al (2011) The role of presurgical expectancies in predicting pain and function one year following total knee arthroplasty. Pain 10:2287–2293
Gutschow CA, Hölscher AH, Leers J et al (2013) Health-related quality of life after Ivor Lewis esophagectomy. Langenbecks Arch Surg 398(2):231–237
Herrero LA, van Vilsteren FGI, Pouw RE et al (2011) Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett’s esophagus longer than 10 cm. Gastrointest Endosc 4:682–690
Pech O, Behrens A, May A et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 9:1200–1206
Hölscher AH, Vallböhmer D, Gutschow C et al (2009) Reflux esophagitis, high-grade neoplasia, and early Barrett’s carcinoma: what is the place of the Merendino procedure? Langenbecks Arch Surg 3:417–424
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zapletal, C., Heesen, C., Origer, J. et al. Quality of Life After Surgical Treatment of Early Barrett’s Cancer: A Prospective Comparison of the Ivor-Lewis Resection Versus the Modified Merendino Resection. World J Surg 38, 1444–1452 (2014). https://doi.org/10.1007/s00268-013-2410-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-013-2410-1